Steven Cohen’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
ACA
Steven Cohen's CYTK Position: Q2 2026 in Review
Steven Cohen increased its Cytokinetics (CYTK) stake by 154% in Q2 2026, buying an estimated $69M and bringing the position to 1,587,712 shares worth $135M. The position accounts for 0.15% of the portfolio, ranked #140.
Steven Cohen first reported a position in CYTK in Q2 2019 and has held it in 25 quarters since. 479 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Steven Cohen held 1,587,712 shares of Cytokinetics worth $135M as of Q2 2026.
- Steven Cohen bought 961,610 Cytokinetics shares in Q2 2026, an estimated $69M.
- Cytokinetics made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #140 holding.
- Steven Cohen first reported a position in Cytokinetics in Q2 2019 and has held it in 25 quarters since.
- 479 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.